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A 10 min treatment of human neutrophils with phorbol 12-myristate 13-acetate (PMA) has been reported 
to induce accumulation of the proteolytically activated Ca 2 +/phospholipid-independent catalytic fragment 
of protein kinase C in the cytosol of intact cells [(1986) J. Biol. Chem. 261, 4101-4105]. We investigated 
the proteolytic conversion of protein kinase C to the Ca 2 +/phospholipid-independent form in the cytosol 
and membrane fractions of pig neutrophils. The activity of protein kinase C was measured with its specific 
oligopeptide substrate Ala-Ala-Ala-Ser-Phe-Lys-Ala-Lys-Lys-amide designed previously. In our experi- 
ments the short-term treatment ofneutrophils with PMA did not induce the accumulation fthe proteolyti- 
cally activated form of protein kinase C in the cytosol of intact ceils. However, treatment ofcells with PMA 
enhanced the limited proteolysis of protein kinase C during the preparation ofcell extracts. 
Protein kinase C; Phorbol ester; Proteolytic activation; Synthetic peptide substrate; 
(Neutrophil, Lymphocyte, Hepatocyte) 
1. INTRODUCTION 
The transient activation of the Ca2+/phospho - 
lipid-dependent protein kinase (protein kinase C) 
by diacylglycerol produced in the cell membrane is
one of  the key events in initiating cellular esponses 
to certain extracellular signals. The tumor pro- 
moter compound phorbol 12-myristate 13-acetate 
(PMA) can substitute for diacylglycerol to activate 
protein kinase C and is widely used to stimulate a
variety of cells (reviews [1,2]). Under in vitro con- 
ditions protein kinase C also can be activated ir- 
reversibly by limited proteolysis [3-6], liberating 
the C-terminal catalytic domain of the enzyme 
from the N-terminal regulatory domain [7]. The 
fragment containing the catalytic domain is active 
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in the absence of Ca 2+ and phospholipid. The con- 
version of protein kinase C to the Ca2+/phos - 
pholipid-independent proteolytic fragment has 
been reported to occur also in intact human 
platelets [8] and neutrophils [9,10] treated for 
10 min with a tumor-promoting phorbol ester. 
Tumor-promoting phorbol esters are considered 
to induce their effects directly by intercalating into 
the cell membrane and permanently activating pro- 
tein kinase C [1,11]. The activated membrane- 
bound protein kinase C phosphorylates a number 
of membrane proteins but cytoplasmic substrates 
of the enzyme are also known [2,12]. The 
mechanism of phosphorylation of cytosolic 
substrates by membrane-bound protein kinase C is 
not known. In human neutrophils treated for 
10 min with PMA the proteolytic cleavage of 
membrane-bound protein kinase C by the 
CaZ+-requiring thiol proteinase calpain and the 
liberation of the catalytic fragment into the cytosol 
have been proposed to account for the 
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phosphorylation of cytosolic or nuclear proteins 
[91. 
While the proteolytic degradation of protein 
kinase C seems to play a role in the down- 
regulation of the phorbol receptor [13,14], the 
physiological significance of the proteolytic activa- 
tion of protein kinase C is an open question. The 
aim of the present studies was to investigate the 
proteolytic activation of protein kinase C in pig 
neutrophils treated for a short time with PMA. 
The catalytic activity of the enzyme was measured 
with the synthetic oligopeptide substrate designed 
previously [15,16]. In the absence of calcium and 
phospholipid the proteolytically activated form of 
protein kinase C has been found to be the single 
enzyme which phosphorylates this oligopeptide 
under standard conditions [15,16]. However, we 
could not observe accumulation of the catalytic 
fragment of protein kinase C in PMA-treated in- 
tact cells. The catalytic fragment was also 
demonstrated in extracts of non-treated cells and 
seemed to be an artifact of the extraction pro- 
cedure. The circumstances which may be responsi- 
ble for the enhancement of limited proteolysis Of 
protein kinase C during extraction of PMA-treated 
cells were investigated in detail. 
2. EXPERIMENTAL 
2.1. Preparation of neutrophil extracts 
Neutrophils were prepared from pig blood ac- 
cording to [17] with the modification that instead 
of Hank's solution neutrophils were suspended in
a medium (medium A) containing 0.01 M sodium 
phosphate (pH 7.4), 5 mM KCI, 120 mM NaCI, 
24 mM NaHCO3 and 5 mM glucose [9]. The cell 
population obtained consisted of 96-97°70 
polymorphonuclear cells, 1-2% lymphocytes and 
1-2o70 monocytes. Living cells accounted for more 
than 97°70 of the cell population. The cells (5 × 106 
cell/ml) were treated with PMA (30 ng/ml) for 
10 min at 37°C according to [9] with the modifica- 
tion that in our experiments he concentration of
PMA was higher. After 10 min incubation the cells 
were centrifuged at 400 × g, then washed and 
suspended in a medium ('lysing medium') compris- 
ing 20 mM Tris-HCl, pH 7.5, 250 mM sucrose, 
2 mM EDTA, 5 mM EGTA, 2 mM phenylmethyl- 
sulphonyl fluoride (PMSF), 10 mM mercapto- 
ethanol and 0.02°7o leupeptin. The suspension (5 x 
106 cells/ml) was cooled in an ice bath and lysed by 
sonication with a Sonic 300 Dismembrator (Artek) 
using 4 x 10 s bursts. The suspension was cen- 
trifuged for 30 min at 100000 x g; the supernatant 
produced was referred to as the cytosol fraction. 
The pellet was suspended in 1 ml lysing buffer con- 
taining 0.2°/o Triton X-100. (The lysing buffer was 
completed again with 2 mM PMSF just before the 
pellet was suspended.) The suspension was in- 
cubated at 0°C for 60 min and centrifuged at 
11000 x g for 15 min. The supernatant yielded by 
this procedure was referred to as the particulate 
fraction. 
2.2. Hepatocyte isolation 
Hepatocytes were isolated from the liver of male 
mice essentially by the collagenase perfusion 
method [18] as detailed in [19]. Isolated 
hepatocytes (about 107 cells/ml) were incubated 
for 10 min in Krebs-Henseleit bicarbonate buffer, 
pH 7.4, containing 1°70 albumin, 8.5 mM glucose, 
5 mM pyruvate, all amino acids necessary for pro- 
tein synthesis (1 mM each), under constant bubbl- 
ing of gas (O2:CO2, 95:5, v/v) at 37°C in the 
absence or presence of 200 ng/ml PMA. Lym- 
phocytes were obtained as a side product during 
the isolation of pig neutrophils. They were treated 
with PMA exactly as the neutrophils. The prepara- 
tion of cell extracts from hepatocytes or lym- 
phocytes was performed as in the case of 
neutrophils. 
2.3. Assay of the activity of  protein kinase C 
The assay was carried out in an assay mixture 
comprising 50 mM Tris-HCl (pH 7.5), 10 mM 
MgCI2, 0.01 mM [32p]ATP (500000-800000 cpm 
per reaction mixture) and the synthetic pep- 
tide Ala-Ala-Ala-Ser-Phe-Lys-Ala-Lys-Lys-amide 
(0.75 mM) in a final volume of 0.4 ml and 0.05-ml 
samples of the extracts were assayed. The activity 
of the proteolytic fragment was measured in ~ the 
presence of 1.25 mM EGTA, while the total activi- 
ty of protein kinase C was determined in the 
presence of 1.25 mM CaC12/20#g/ml phospha- 
tidylserine/25 ng/ml PMA. Incubation was car- 
ried out at 37°C for 10 min. Radioactivity incor- 
porated into the oligopeptide substrate was 
measured as in [14]. Assays were performed in 
duplicates. 
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2.4. Separation of the proteolytic fragment from 
the intact protein kinase C 
Cell were sonicated in lysing buffer in the 
presence of 0.01 mM cAMP, the cytosol fraction 
being diluted 10 times with distilled water contain- 
ing 0.01 mM cAMP and 2 mM PMSF and applied 
immediately onto a DEAE-Sephacel column (1 x 
10 cm). Chromatography was carried out as in 
[141. 
3. RESULTS AND DISCUSSION 
Extracts of pig neutrophils were prepared in the 
presence of the usual protease inhibitors. Leupep- 
tin (0.02%) or pepstatin (30#g/ml) did not in- 
fluence significantly the conversion of protein 
kinase C to the proteolytically activated form but 
PMSF was an effective inhibitor of limited pro- 
teolysis in neutrophil extracts. However, in spite of 
the presence of PMSF, in freshly prepared extracts 
of pig neutrophils the calcium/phospholipid- 
independent activity accounted for 25-30% of the 
total protein kinase C activity measured with the 
synthetic oligopeptide substrate (table 1). Storage 
of the cytosol fraction at 0°C for 2-3 h resulted in 
the complete loss of the intact enzyme. 
The intact and proteolytically activated forms of 
protein kinase C were demonstrated by DEAE- 
cellulose chromatography (fig.l). The pro- 
teolytically activated form of the enzyme was 
eluted in the known position, at higher ionic 
strength than the intact enzyme [3,8,9,15,16] and 
was inhibited by calcium/phosphatidylserine as 
mentioned previously [16]. 
Treatment of cells with PMA (30 ng/ml) for 
10 min caused translocation of protein kinase C. 
Table 1 
The activity of protein kinase C and its proteolytic 
fragment in subceUular fractions of pig neutrophils 
Subcellular fractions Peptide kinase activity 
(pmol/min per 107 cells) 
(mean _+ SE; n = 7) 
in the presence of 
EGTA Ca2+/pS/PMA 
Cytosolic 44 _+ 6 190 _+ 9 
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Fig. I. Separation of intact and proteolytically activated 
forms of protein kinase C by DEAE-cellulose 
chromatography. Cytosol fraction was prepared from 
5 x 106 neutrophils and chromatography was performed 
as described in the text. About 4-ml fractions were 
collected and 0.l-ml samples were assayed for peptide 
kinase activity in the presence of 1 mM EGTA (o---o) 
or CaC12 (l mM)/phosphatidylserine (20#g/ml)/PMA 
(25 ng/ml) (o o). 
The intact enzyme which disappeared from the 
cytosol was found in the particulate fraction 
(fig.2A,B). It is important to note that in the pre- 
sent experiments the concentration of Triton 
X-100 was 0.025% in the assay mixture for the par- 
ticulate fraction. At this concentration the in- 
hibitory effect of Triton on the activation of intact 
enzyme was slight. Accumulation of the pro- 
teolytically activated fragment of protein kinase C 
in the cytosol of intact PMA-treated neutrophils 
was not observed (fig.2). More exactly, in 3 out of 
7 similar experiments performed with different 
batches of neutrophils the amount of proteolytic 
fragment did not increase at all in extracts of 
PMA-treated cells (fig.2A,B), while in the other 4 
cases a small (never more than the 15% of the total 
protein kinase C activity) increase in 
calcium/phospholipid-independent activity was 
detected but exclusively in the particulate fraction. 
We can state that in pig neutrophils the PMA- 
induced translocation of protein kinase C was not 
accompanied by liberation of the proteolytically 
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Fig.2. Translocation of protein kinase C from the 
cytosol into the particulate fraction of pig neutrophils on 
the effect of PMA. Neutrophils were incubated in the 
absence (A,C) or presence of 30 ng/ml PMA (B,D). 
Cells were sonicated in lysing medium, and membranes 
were solubilised in lysing medium containing 0.2% 
Triton X-100. In A,B this medium was completed again 
with 2 mM PMSF immediately before the membrane 
pellet was suspended. In C,D lysing medium was not 
completed again with PMSF before the membrane was 
suspended. A,B and C,D show results obtained from 
different batches of neutrophils. Peptide kinase activity 
was measured in the presence of 1.25 mM EGTA (open 
columns) or in the presence of 1.25 mM CaC12/20/zg /ml  
phosphatidylserine/25 ng/ml PMA (hatched columns). 
S, cytosol fraction; P, particulate fraction. The peptide 
kinase activity of the extracts was measured immediately 
after preparation. Data are means of duplicate 
determinations. A,B and C,D each represent one out of 
7 and 4 similar experiments, respectively. 
activated form into the cytosol, at variance with 
the result in [9]. 
Since we were unable to reproduce the 
phenomenon demonstrated in [9] we investigated 
the conditions which differed in our experiments 
from those reported in [9]. According to the 
descriptions of the experimental procedures of [9] 
in a part of the experiments demonstrating ac- 
cumulation of the catalytic fragment in the cytosol 
of intact PMA-treated neutrophils, protease in- 
hibitors were not used at all during the course of 
the preparation of the cellular extracts. Therefore, 
we performed a series of experiments without in- 
hibition of the extracellular proteolysis of protein 
kinase C. When PMSF was present in the lysing 
medium but the medium used for the solubilisation 
of the particulate fraction was not completed with 
PMSF just before the membrane pellet was 
suspended, the treatment of cells with PMA in- 
duced not only the translocation of protein kinase 
C from the cytosol into the membrane but the en- 
zyme found in the particulate fraction was also 
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Fig.3. Effect of treatment of lymphocytes and 
hepatocytes with PMA on the activity of protein kinase 
C in extracts of cells. Pig lymphocytes were incubated in 
the absence (A) or presence of 30 ng/ml PMA (B). 
Isolated mouse hepatocytes were incubated in the 
absence (C) or presence (D) of 200 ng/ml PMA. 
Extracts were prepared in the presence of 2 mM PMSF 
and 0.02% leupeptin. Peptide kinase activity was 
~measured in the presence of 1.25 mM EGTA (open 
columns) or in the presence of 1.25 mM CaC12/20/zg/ml 
phosphatidylserine/25 ng/ml PMA (hatched columns). 
S, cytosol fraction; P, particulate fraction. Data are 
means of duplicate determinations. 
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tivated form (fig.2C,D). Exactly the same 
phenomenon has been described in the case of 
PMA-treated thrombocytes [8]. When PMSF was 
present during the sonication but the sonicated cell 
suspension was stored for several minutes at room 
temperature before centrifugation, the amount of 
the proteolytic fragment of protein kinase C was 
significantly higher in the cytosol fraction of 
PMA-treated cells than in control cells (not 
shown). 
It is known that the reversible activation of pro- 
tein kinase C by phospholipid and diacylglycerol 
stimulates in vitro proteolysis of the enzyme by the 
calcium-dependent thiol proteinase calpain I, 
because calpain I reacts preferentially with the ac- 
tive form of protein kinase C [6]. The active form 
of the enzyme produced by treatment of cells with 
PMA also seems to be more susceptible than the 
inactive form to in vitro attack of some serine pro- 
teinases of the neutrophils. Our results led us to the 
conclusion that in pig neutrophils the proteolytic 
activation of protein kinase C has no physiological 
significance in the PMA-induced effects during the 
first 10 rain. 
In neutrophil extracts protection of the intact 
protein kinase C against in vitro proteolysis was 
very difficult, however, this was not easy either in 
the extracts of other cell types. We also in- 
vestigated the PMA-induced translocation of pro- 
tein kinase C in pig lymphocytes and isolated 
mouse hepatocytes. Hepatocytes were treated with 
200 ng/ml PMA instead of 30 ng/ml, and at 
variance with neutrophil and lymphocyte xtracts 
the presence of leupeptin (0.02%) was essential for 
preservation of the activity of protein kinase C in 
hepatocyte xtracts. In spite of careful inhibition 
of the extracellular proteolysis, in the extracts of 
both cell types a small amount of the proteolytical- 
ly activated fragment was observed and a small 
enhancement of proteolytic onversion in extracts 
of PMA-treated cells could be detected (fig.3). In 
a single case out of 5 similar experiments he pro- 
teolytic fragment was not found in the extracts of 
hepatocytes, either of the control or of PMA- 
treated cells. Our results uggest that data concern- 
ing the proteolytic activation of protein kinase C in 
intact cells on the effect of a short-term treatment 
with PMA can be evaluated only under conditions 
where extracellular proteolysis is completely in- 
hibited. The synthetic oligopeptide substrate of 
protein kinase C may provide a tool to check the 
methods used for the protection of intact protein 
kinase C during the preparation of cellular ex- 
tracts. 
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